US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jul 2, 2013 (13 years ago)

PHYTONADIONE Tablet

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling: Label Mixup; PHYTONADIONE Tablet, 5 mg may be potentially mislabeled as medroxyPROGESTERone ACETATE, Tablet, 10 mg, NDC 59762374202, Pedigree: AD46312_19, EXP: 5/16/2014; HYDROCORTISONE, Tablet, 5 mg, NDC 00603389919, Pedigree: W003060, EXP: 6/12/2014; GALANTAMINE HBR ER, Capsule, 24 mg, NDC 47335083783, Pedigree: W003735, EXP: 5/31/2014; TORSEMIDE, Tablet, 10 mg, NDC 31722053001,

What was recalled

PHYTONADIONE Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 25010040515

Recalling firm
Aidapak Services, LLC
Origin
WA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-539-2014

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Phytonadione recalls

See all
Class II · Moderate risk Ongoing

Phytonadione Injectable Emulsion

Reason Failed Stability Specifications: Observed OOS results: eg results for colour index

Cipla Limited NDC 69097-708-31 D-0197-2026
Class II · Moderate risk Terminated

Vitamin K

Reason Lack of sterility assurance

Sentara Infusion Services D-0324-2023
Class III · Low risk Completed

Phytonadione Injectable Emulsion USP

Reason Failed Stability Specifications: Out of specification results reported at 12-month stability testing for aluminum content.

Dr. Reddy's Laboratories, Inc. NDC 43598-405-16 D-0007-2023
Class III · Low risk Terminated

Phytonadione Tablets 5 mg

Reason Failed Impurities Specification: Out of specification when measuring the impurity degradant D level.

AVKARE Inc. NDC 50268-661-13 D-0631-2021
Class III · Low risk Terminated

Phytonadione Tablets

Reason Failed Impurities/Degradation Specifications

Bausch Health Companies, Inc. NDC 68682-170-30 D-0639-2021